Year: 2023
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Increasing evidence suggests that reactive astrocytes are associated with Alzheimer's disease (AD). However, its underlying pathogenesis remains unknown. Given the role of astrocytes in energy metabolism, reactive astrocytes may contribute to altered brain energy metabolism. Astrocytes are primarily considered glycolytic cells, suggesting a preference for lactate production. This study aimed to examine alterations in astrocytic activities and their association with brain lactate levels in AD. METHODS: F]florzolotau, respectively. Myo-inositol, an astroglial marker, and lactate in the posterior cingulate cortex were quantified by magnetic resonance spectroscopy. These magnetic resonance spectroscopy metabolites were compared with plasma biomarkers, including glial fibrillary acidic protein as another astrocytic marker, and amyloid and tau positron emission tomography. RESULTS: Myo-inositol and lactate levels were higher in AD patients than in cognitively unimpaired participants (p < 0.05). Myo-inositol levels correlated with lactate levels (r = 0.272, p = 0.047). Myo-inositol and lactate levels were positively associated with the Clinical Dementia Rating sum-of-boxes scores (p < 0.05). Significant correlations were noted between myo-inositol levels and plasma glial fibrillary acidic protein, tau phosphorylated at threonine 181 levels, and amyloid and tau positron emission tomography accumulation in the posterior cingulate cortex (p < 0.05). INTERPRETATION: We found high myo-inositol levels accompanied by increased lactate levels in the posterior cingulate cortex in AD patients, indicating a link between reactive astrocytes and altered brain energy metabolism. Myo-inositol and plasma glial fibrillary acidic protein may reflect similar astrocytic changes as biomarkers of AD. ANN NEUROL 2024;95:104-115.
Source: Annals of Neurology
DOI: 10.1002/ana.26797
Authors: Kosei Hirata, Kiwamu Matsuoka, Kenji Tagai, Hironobu Endo, Harutsugu Tatebe, Maiko Ono, Naomi Kokubo, Asaka Oyama, Hitoshi Shinotoh, Keisuke Takahata, Takayuki Obata, Masoumeh Dehghani, Jamie Near, Kazunori Kawamura, Ming‐Rong Zhang, Hitoshi Shimada, Takanori Yokota, Takahiko Tokuda, Makoto Higuchi, Yuhei Takado
Institutions: Tokyo Medical and Dental University, National Institutes for Quantum Science and Technology, Institute for Quantum Medical Science, Institute for Quantum Life Science, Sunnybrook Research Institute, University of Toronto, Brain Research Institute, Niigata University, Niigata University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,610
Awards: 脳老化病態カスケードのトランスレータブルなイメージングとメカニズム制御の研究開発, G262964011, G3301964346, Elucidation and modulation of neural dysfunction mechanisms induced by alpha-synuclein propagation, G3740494178, Understanding the plasticity mechanisms of the brain through excitatory-inhibitory balance modulation., PET evaluation of pathological diversity in dementia towards the establishment of novel diagnostic and therapeutic strategies, G5177381782, Development of blood-brain barrier-crossing antibodies utilizing the biological features of glucose transporters, タウを標的とする新規画像診断法と治療法の研究開発コンソーシアム構築, G6003102683, 神経過興奮とタウ放出・伝播の悪循環を標的とする認知症の病態解明と治療法開発, Development of Astrocyte Imaging Biomarkers Using Hyperpolarized MRS and DREADD, Etiological assessments of neurodegenerative dementias by in-vivo imaging of pathological protein aggregates in the brain
OpenAlex ID: W4386699208
